Associate Director/Director, Gene Therapy Operations

The role

This field-based role manages treatment center onboarding, patient coordination, apheresis support, and drug product delivery. The individual will drive operational readiness and execution for the lead asset, risto-cel, across a treatment center network.

What you will do

• Lead operational on-site onboarding, training, and qualification of apheresis and treatment centers
• Conduct operational readiness assessments
• Support treatment center activation and certification
• Coordinate patient scheduling across apheresis, manufacturing, and infusion
• Act as the field escalation point for scheduling challenges
• Provide hands-on apheresis expertise and guidance to treatment centers
• Support cell collection optimization
• Support treatment centers with drug product receipt, storage, thawing, and administration readiness
• Ensure adherence to Chain of Identity and Chain of Custody processes
• Serve as the primary operational point of contact for treatment center stakeholders

Required qualifications

• Bachelor’s degree
• 10+ years of experience
• 8+ years of healthcare experience, including experience in cell & gene therapy or apheresis operations
• Direct hands-on apheresis experience
• Strong understanding of apheresis and cell collection processes
• Strong understanding of cell therapy workflows (COI/COC, product handling, infusion)
• Strong understanding of regulatory standards (FACT, AABB, GxP)
• Ability to operate independently in a field-based, highly matrixed environment
• Strong problem-solving and escalation management skills
• Excellent training, teaching, and clinical communication abilities
• High attention to detail with a strong focus on quality and compliance
• Willingness to travel >60%

Nice to have

• advanced degree (RN, BSN, MPH, MBA)
• Experience supporting treatment center onboarding and/or commercial CGT operations
• Experience with autologous CGT products and SCD

About the company

Beam Therapeutics is a biotechnology company with an integrated platform for precision genetic medicines using base editing technology. The organization is committed to providing life-long cures to patients suffering from serious diseases.